Bridge Point Capital logo

Bridge Point Capital

North America, New York, United States, New York

Description

Cross-border private equity firm dedicated to actively pursuing growth stage investment opportunities in the United States

Investor Profile

Bridge Point Capital has backed more than 2 startups, with 1 new investments in the last 12 months alone. The firm has led 1 rounds, about 50% of its total and boasts 0 exits across its portfolio.

Investment Focus Highlights

  • Concentrates on Series E, Series Unknown rounds (top funding stages).
  • Majority of deals are located in United States.
  • Strong thematic focus on Health Care, Biotechnology, Medical.

Stage Focus

  • Series E (50%)
  • Series Unknown (50%)

Country Focus

  • United States (100%)

Industry Focus

  • Health Care
  • Biotechnology
  • Medical
  • Medical Device
  • Software
  • Therapeutics
circle-line
FAQ

Frequently Asked Questions

Learn who this investor regularly partners with—both firms and angels—and explore their latest activity.

Who does Bridge Point Capital frequently co-invest with?

SP
North America, Massachusetts, United States, Cambridge
Co-Investments: 1
Prox Ventures
Asia, Shanghai, China, Shanghai
Co-Investments: 1
Norwest Venture Partners
North America, California, United States, Palo Alto
Co-Investments: 1
ONCE Ventures
North America, California, United States, Los Angeles
Co-Investments: 1
RYSE Asset Management
Europe, England, United Kingdom, London
Co-Investments: 1
Avestria Ventures
North America, California, United States, San Francisco
Co-Investments: 1

What are some of recent deals done by Bridge Point Capital?

Chime Software

Watford, Hertford, United Kingdom

Chime Software is a software platform.

ComputerConsumer SoftwareService IndustrySoftware
Private EquityOct 6, 2025
Curio

Princeton, New Jersey, United States

Curio is a digital therapeutics company.

Health CareSoftwareTherapeutics
Series UnknownAug 28, 2024
Clerio Vision

Rochester, New York, United States

Clerio Vision is developing a revolutionary product platform for the global ophthalmic market.

BiotechnologyHealth CareMedicalMedical Device
Series EFeb 3, 2021
Amount Raised: $12,500,000

Find More Investors Like Bridge Point Capital

Discover similar investors in our database and build your perfect investor list.

Need help with your fundraising strategy?Read our fundraising guides

Bridge Point Capital | Pipeseed